Aniracetam was the second racetam developed by Dr. Corneliu Giurgea after piracetam. Piracetam, which began it’s life as a cyclic derivative of the primary inhibitory neurotransmitter GABA was modified in the 70’s to create the related racetam, aniracetam. Oddly enough, there are studies that may suggest that aniracetam itself may not
> View article
Follow Us!